Meet IQVIA at BOOTH #F27
The annual premier drug development life science event is back. With the theme “Advancing the value of innovation in regulation, R&D and global accessibility,” DIA China 2026 brings together patient representatives, leading scientists, regulators, and advocates of innovative drug accessibility. This year's conference connects the full value chain — from R&D and market access to patient care.
New for 2026, DIA Biotech Day will further expand the agenda. The event is expected to host 6,000+ industry experts, 400+ exhibitors, and drug agencies from 30+ countries
IQVIA will host a dedicated workshop featuring IQVIA experts and industry leaders discussing key aspects of clinical development. The workshop opens with Leanne Magné, SVP, Head of Research & Development Solutions, IQVIA JAPAC presenting on the Global R&D Landscape and Emerging Trends. The session will cover different clinical areas including:
- China Clinical Ecosystem: Integrating Local Expertise into Global Programs
- Scaling Obesity Trials with Patient-Centric Research Models
- Regional Collaboration in Europe: Enabling Efficient Clinical Delivery
- Driving Early Phase Oncology Success through Specialized Site Networks Stay tuned for more updates
Related solutions
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
